EQA for clinical DNA methylation-based episignature analysis. Please contact office@emqn.org if you are interested in participating in this EQA.
This EQA will provide independent assessment, external benchmarking and educational feedback for laboratories performing episignature testing and will evaluate both the technical generation of methylation data and the clinical interpretation of episignature results.
01-EPI-27
Assessment of episignature methylation analysis
Array based, Methylation
DNA (in TE Buffer)
Polish
No
09/11/2026
To be finalised
To be finalised (for exact dates, please see scheme instructions)
To be finalised (for exact dates, please see scheme instructions)
More detail to be provided
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Participants are expected to test samples according to their routine strategy, to return a clinical report and to complete the data collection form.
Please contact office@emqn.org if you are interested in participating in this EQA.
Closing Soon
Closes today
From £650.00
Buying is completed on the EMQN portal and needs a free EMQN account, which takes a few minutes to set up.
Questions about this scheme?
Contact our team
Express your interest in ''.